⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8244 | 1.00 | — | — | |
| SCHEMBL6027700 | 1.00 | — | — | |
| SCHEMBL30391170 | 0.97 | GRIK1 (0.58) | — | |
| SCHEMBL28659265 | 0.97 | GRIK1 (0.58) | — | |
| Hydrochloric Acid SCHEMBL376814 | 0.97 | GRIK1 (0.58) | — | |
| Phosphoric Acid SCHEMBL2150696 | 0.91 | GRIK1 (0.52) | — | |
| SCHEMBL29098570 | 0.87 | GRIK1 (0.48) | — | |
| SCHEMBL874270 | 0.84 | SLC7A5 (0.58) | — | |
| SCHEMBL21447999 | 0.84 | SLC7A5 (0.58) | — | |
| SCHEMBL877833 | 0.84 | SLC7A5 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106537145-B | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2020-08-25 | — | — | CN | claimed |
| EP-3454883-A1 | STABILIZED GLYCOPEPTIDE ANTIBIOTIC FORMULATIONS | Xellia Pharmaceuticals ApS (DK) | 2019-03-20 | — | — | EP | claimed |
| WO-2017194385-A1 | STABILIZED GLYCOPEPTIDE ANTIBIOTIC FORMULATIONS | XELLIA PHARMACEUTICALS APS (DK) | 2017-11-16 | — | — | WO | claimed |
| EP-1689703-A1 | RESOLUTION OF 3-AMINO ALKYLNITRILES | Pfizer Products Inc. (US) | 2006-08-16 | — | — | EP | claimed |
| WO-2005040097-A1 | RESOLUTION OF 3-AMINO ALKYLNITRILES | PFIZER PRODUCTS INC. (US) | 2005-05-06 | — | — | WO | claimed |
| US-20250288640-A1 | GLYCOPEPTIDE COMPOSITIONS | HIKMA PHARMACEUTICALS USA INC. (US) | 2025-09-18 | — | — | US | disclosed |
| US-12161690-B2 | Glycopeptide compositions | HIKMA PHARMACEUTICALS USA INC. (US) | 2024-12-10 | — | — | US | disclosed |
| WO-2024249950-A1 | FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF MENIN | BIOMEA FUSION, INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| WO-2024146502-A1 | WEE1 DEGRADING COMPOUNDS | BEIJING NEOX BIOTECH LIMITED (CN) | 2024-07-11 | — | — | WO | disclosed |
| CN-116888138-A | Radiopharmaceutical conjugate compositions and uses thereof | 瑞择生物公司 | 2023-10-13 | — | — | CN | disclosed |
| EP-4209483-A1 | PRODRUG MODULATORS OF THE INTEGRATED STRESS PATHWAY | Calico Life Sciences LLC (US) | 2023-07-12 | — | — | EP | disclosed |
| EP-4192247-A1 | ANTIBACTERIAL COMPOSITIONS AND METHODS FOR FABRICATING THEREOF | Harrow IP, LLC (US) | 2023-06-14 | — | — | EP | disclosed |
| EP-1689703-A1 | RESOLUTION OF 3-AMINO ALKYLNITRILES | Pfizer Products Inc. (US) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005040097-A1 | RESOLUTION OF 3-AMINO ALKYLNITRILES | PFIZER PRODUCTS INC. (US) | 2005-05-06 | — | — | WO | disclosed |
| US-5124257-A | Culturing of microorganisms of brevibacterium or corynebacterium requiring D-alanine for their growth and recovering L-alanine | AZIZIAN ASMIK G (SU) | 1992-06-23 | — | — | US | disclosed |
| EP-0015771-B1 | N-(6-((ACYLAMINOACYLAMINO OR AMINOACYLAMINO)PHENYL)-1,2-DIHYDRO-2-OXONICOTINYL) CEPHALOSPORIN COMPOUNDS, PROCESSES FOR THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THE SAME | WARNER-LAMBERT COMPANY (US) | 1984-06-06 | — | — | EP | disclosed |
| US-4311698-A | Aminoacid derivatives of cephalosporin compounds | HASKELL THEODORE H | 1982-01-19 | — | — | US | disclosed |
| US-4311699-A | Aminoacid derivatives of cephalosporin compounds | HASKELL THEODORE H | 1982-01-19 | — | — | US | disclosed |
| EP-0015772-A1 | N-(2-((acylaminoacylamino or aminoacylamino)phenyl)-4-hydroxy-5-pyrimidinylcarbonyl)cephalosporin compounds, processes for their production, and compositions containing the same | WARNER-LAMBERT COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |
| EP-0015771-A1 | N-(6-((acylaminoacylamino or aminoacylamino)phenyl)-1,2-dihydro-2-oxonicotinyl) cephalosporin compounds, processes for their production, and compositions containing the same | WARNER-LAMBERT COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |